AGM Details

The 30th Annual General Meeting of Orkla India Limited is scheduled to be held on Wednesday, August 19, 2026 at 03:00 P.M. (IST) through Video Conferencing/Other Audio Visual Means without physical presence of shareholders.

The proceedings are deemed to be conducted at the Registered Office of the Company: No. 1, 2nd & 3rd Floor, 100 Feet Inner Ring Road, Ejipura, Ashwini Layout, Viveknagar, Bengaluru - 560 047, India.

Ordinary Business Items

Item 1: Adoption of Financial Statements

To receive, consider and adopt the Audited Financial Statements (both Standalone and Consolidated) of the Company for the Financial Year ended March 31, 2026, together with the reports of the Board of Directors and Auditors thereon.

Item 2: Director Re-appointment

To appoint a Director in the place of Mr. Per Haavard Skiaker Maelen (DIN: 10138903), who retires by rotation and being eligible, offers himself for re-appointment.

Mr. Per Haavard Skiaker Maelen is Senior Vice President and Investment Director of Orkla ASA and serves as Chairman and Director of Health and Sports Nutrition Group HSNG AB and as Director on the Boards of Orkla Asia Holding AS, Orkla Food Ingredients AS and Orkla Investeringer AS.

He holds a Bachelor (Hons) degree in Business Administration from European Business School London and brings over two decades of experience in FMCG and investment banking sector.

Attendance record: Board Meetings (15 out of 15), Audit Committee (10 out of 10), Nomination and Remuneration Committee (1 out of 1).

The Company does not propose to pay any remuneration or sitting fees to him.

Special Business Items

Item 3: Ratification of Employee Stock Option Plan 2025

Special Resolution to ratify the 'Employee Stock Option Plan 2025' (ESOP 2025) originally approved by Board on May 12, 2025 and Shareholders on May 16, 2025 prior to IPO.

Key Details:

  • Maximum ESOPs: 27,39,784 (Twenty Seven Lacs Thirty Nine Thousand Seven Hundred Eighty Four) options, being not more than 2% of total share capital
  • Each option exercisable into 1 equity share of face value ₹1 each
  • Vesting period: Fixed 3 years from Grant Date (inclusive of minimum 1 year required by law)
  • Exercise period: 2 years from vesting date while in employment
  • Maximum grant per employee: Not to exceed 1% of issued capital in any one year

Item 4: Extension of ESOP 2025 to Subsidiary/Holding Company Employees

Special Resolution to ratify extension of ESOP 2025 benefits to eligible employees of subsidiary(ies) and holding company, within the overall limit of 27,39,784 options.

Item 5: Ratification of Management Stock Option Plan 2025

Special Resolution to ratify the 'Management Stock Option Plan 2025' (MSOP 2025) originally approved by Board on May 12, 2025 and Shareholders on May 16, 2025 prior to IPO.

Key Details:

  • Maximum MSOPs: 4,70,000 (Four Lacs Seventy Thousand) options, being not more than 0.34% of total share capital
  • Each option exercisable into 1 equity share of face value ₹1 each
  • Vesting: Later of (i) expiry of 1 year from Grant Date, or (ii) date when company is listed on recognized stock exchanges
  • Exercise period: 1 year from vesting date while in employment

Item 6: Extension of MSOP 2025 to Subsidiary/Holding Company Employees

Special Resolution to ratify extension of MSOP 2025 benefits to eligible management employees of subsidiary(ies) and holding company, within the overall limit of 4,70,000 options.

Voting and Meeting Participation Details

Remote E-voting

  • Platform: NSDL e-voting system (https://www.evoting.nsdl.com/)
  • Cut-off date: Wednesday, August 12, 2026
  • Voting period: Commences Sunday, August 16, 2026 at 9:00 a.m. (IST) and concludes Tuesday, August 18, 2026 at 5:00 p.m. (IST)
  • Results publication: On or before Friday, August 21, 2026

Virtual Meeting Access

  • Shareholders can join the AGM 15 minutes before and after scheduled time through NSDL e-voting system
  • Facility available for 1,000 shareholders on first-come-first-served basis (excludes large shareholders, promoters, institutional investors, directors, KMPs, committee chairpersons, auditors)
  • Shareholders must register as speakers by sending request to investors@orklaindia.com from August 13-16, 2026 to ask questions during AGM

Additional Information

  • The Notice and Annual Report are available on company website: https://www.orklaindia.com/governance/
  • Physical copies available on request to shareholders
  • Dematerialization of shares is mandatory as per SEBI regulations
  • Shareholders must update their details with DP (for demat holdings) or Company/RTA (for physical holdings)

Explanatory Statement

The ESOP 2025 and MSOP 2025 were formulated pre-IPO and require ratification post-IPO as per Regulation 12(1) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The purpose is to attract, retain and motivate employees by offering them opportunity to participate in company's future growth.

None of the Directors and Key Managerial Personnel of the Company, including their relatives, are interested or concerned in the resolutions, financially or otherwise, except to the extent they may be lawfully granted options under ESOP 2025 and MSOP 2025.